Abstract
In this work, water-compatible molecularly imprinted polymers (MIPs) were prepared for fast, accurate and selective solid-phase extraction of verapamil (VPM) from complex matrices such as biological fluids and human urine followed by its UV spectroscopic determination at 278 nm. The effective factors influencing the precipitation polymerization have been studied. Molecular recognition properties, binding capability and selectivity of the MIPs were evaluated and the results revealed that the obtained MIPs have high affinity for VPM in aqueous media. Equilibrium binding experiments were done to assess the performance of the MIP relative to non imprinted polymer (NIP). After optimization of molecularly imprinted solid-phase extraction (MISPE) method with 2 mL water plus 2 mL acetone as washing solvents and 5 mL of methanol and acetic acid (10:1, v/v) as elution solvent, successful imprinting was confirmed by comparison of the recoveries between NIP (4%) and MIP (97%) polymers. The binding capacity of the MIP for VPM was determined to be 196 mg g-1 (400 μmol g-1). Accuracy and precision were checked by the HPLC technique and the results did not present significant difference at 95% confidence levels according to the t-test.
Keywords: Molecularly imprinted polymer, Solid-phase extraction, Verapamil, Biological fluids, Human urine
Current Pharmaceutical Analysis
Title: Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine
Volume: 5 Issue: 3
Author(s): Mehran Javanbakht, Narges Shaabani, Majid Abdouss, Mohammad R. Ganjali, Ali Mohammadi and Parviz Norouzi
Affiliation:
Keywords: Molecularly imprinted polymer, Solid-phase extraction, Verapamil, Biological fluids, Human urine
Abstract: In this work, water-compatible molecularly imprinted polymers (MIPs) were prepared for fast, accurate and selective solid-phase extraction of verapamil (VPM) from complex matrices such as biological fluids and human urine followed by its UV spectroscopic determination at 278 nm. The effective factors influencing the precipitation polymerization have been studied. Molecular recognition properties, binding capability and selectivity of the MIPs were evaluated and the results revealed that the obtained MIPs have high affinity for VPM in aqueous media. Equilibrium binding experiments were done to assess the performance of the MIP relative to non imprinted polymer (NIP). After optimization of molecularly imprinted solid-phase extraction (MISPE) method with 2 mL water plus 2 mL acetone as washing solvents and 5 mL of methanol and acetic acid (10:1, v/v) as elution solvent, successful imprinting was confirmed by comparison of the recoveries between NIP (4%) and MIP (97%) polymers. The binding capacity of the MIP for VPM was determined to be 196 mg g-1 (400 μmol g-1). Accuracy and precision were checked by the HPLC technique and the results did not present significant difference at 95% confidence levels according to the t-test.
Export Options
About this article
Cite this article as:
Javanbakht Mehran, Shaabani Narges, Abdouss Majid, Ganjali R. Mohammad, Mohammadi Ali and Norouzi Parviz, Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine, Current Pharmaceutical Analysis 2009; 5 (3) . https://dx.doi.org/10.2174/157341209788922011
DOI https://dx.doi.org/10.2174/157341209788922011 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Tenofovir-Related Nephropathies in HIV-Infected Patients
Current Vascular Pharmacology Contemporary Treatment of Amyloid Heart Disease
Current Pharmaceutical Design Pyrrolo-isoxazole: A Key Molecule with Diverse Biological Actions
Mini-Reviews in Medicinal Chemistry Improving Pediatric Survival from Resuscitation Events: The Role and Organization of Hospital-based Rapid Response Systems and Code Teams
Current Pediatric Reviews Neurotrophic Factors as a Protective Strategy in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for?
Current Hypertension Reviews Editorial (Thematic Issue: Stereoselective Synthesis and Applications of Compounds with N-O Bonds)
Current Organic Synthesis Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment
Current Pharmaceutical Design Molecular Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Hemodialysis Patients
Current Signal Transduction Therapy On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?
Current Neuropharmacology Preclinical Evaluation of New Anthracyclines
Current Medicinal Chemistry Pathophysiology, Diagnosis and Clinical Management of Hepatorenal Syndrome: From Classic to New Drugs
Current Vascular Pharmacology Editorial (Thematic Issue: Biological Toxins and Medicinal Chemistry: Research and Therapeutic Tools)
Current Topics in Medicinal Chemistry Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders
CNS & Neurological Disorders - Drug Targets Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies
Current Drug Targets Pathomechanisms of Myocardial Dysfunction in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets